Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mildred Gottwald"'
Autor:
Stephen A Harrison, Manal F Abdelmalek, Guy Neff, Nadege Gunn, Cynthia D Guy, Naim Alkhouri, Mustafa R Bashir, Bradley Freilich, Anita Kohli, Arun Khazanchi, Muhammad Y Sheikh, Mark Leibowitz, Mary E Rinella, Mohammad S Siddiqui, Mark Kipnes, Sam E Moussa, Ziad H Younes, Meena Bansal, Seth J Baum, Brian Borg, Peter J Ruane, Paul J Thuluvath, Mildred Gottwald, Mujib Khan, Charles Chen, Liza Melchor-Khan, William Chang, Alex M DePaoli, Lei Ling, Hsiao D Lieu
Publikováno v:
The lancet. Gastroenterologyhepatology. 7(7)
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis, inflammation, and injury, and is associated with an increased risk of liver transplantation and death. NASH affects more than 16 million people in the USA, and there is no ap
Autor:
Kristin Nelson, Hsiao D. Lieu, Mildred Gottwald, James F. Trotter, Guy W. Neff, Nadege Gunn, Alex M. DePaoli, Sam E. Moussa, Ziad Younes, Andrew Yan, Mustafa R. Bashir, Angelo H. Paredes, Juan P. Frias, William C.G. Chang, Cynthia D. Guy, Stephen A. Harrison, Lei Ling, Anita Kohli
Publikováno v:
Gastroenterology. 160(1)
Background & Aims Aldafermin, an engineered analog of fibroblast growth factor 19, inhibits bile acid synthesis and regulates metabolic homeostasis. We report results from a 24-week, phase 2 study, with serial liver biopsies, of patients with nonalco
Autor:
Stephen A. Harrison, Guy Neff, Cynthia Guy, Mustafa Bashir, Angelo Paredes, Juan Frias, Ziad H. Younes, James F. Trotter, Nadege T. Gunn, Sam Moussa, Anita Kohli, Kristen Nelson, Mildred Gottwald, William Chang, Andrew Yan, Alex Depaoli, Lei Ling, Hsiao Lieu
Publikováno v:
Journal of Hepatology. 73:S114-S115
Autor:
Ori Ben-Yehuda, Martine Allard, Nicola Pannacciulli, Heather Zhang, Phil Jochelson, Jolene Berg, Axel Juan, Julia Zack, Yongwu Shao, Mildred Gottwald
Publikováno v:
Clinical Pharmacology in Drug Development. 4:121-129
Ranolazine and metformin may be frequently co-administered in subjects with chronic angina and co-morbid type 2 diabetes mellitus (T2DM). The potential for a drug-drug interaction was explored in two phase 1 clinical studies in subjects with T2DM to
Autor:
Julia, Zack, Jolene, Berg, Axel, Juan, Nicola, Pannacciulli, Martine, Allard, Mildred, Gottwald, Heather, Zhang, Yongwu, Shao, Ori, Ben-Yehuda, Phil, Jochelson
Publikováno v:
Clinical pharmacology in drug development. 4(2)
Ranolazine and metformin may be frequently co-administered in subjects with chronic angina and co-morbid type 2 diabetes mellitus (T2DM). The potential for a drug-drug interaction was explored in two phase 1 clinical studies in subjects with T2DM to